Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05095935 · ClinicalTrials.gov registry record
Medtronic Signia SDR Product Surveillance Registry
A clinical trial, sponsored by Medtronic.
- Completed
- Registry status
- 430
- Enrollment target
NCT05095935 is a clinical trial that has completed, run by Medtronic. The registered enrollment target is 430 participants.
The verdict
NCT05095935 has completed, sponsored by Medtronic.
- COMPLETED
- Registry status
- 430 participants
- Enrollment target
Study Summary
The purpose of the registry is to confirm the safety and performance of the Signia™ Small Diameter Reload (SDR) when used in surgical procedures in a real-world setting in patients receiving surgery for indicated thoracic, abdominal, and pediatric applications, intraoperatively.
Interventions
- OTHER N/A observational registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2021-08-10 |
| Est. Completion | 2024-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05095935
The ClinicalTrials.gov registry entry for NCT05095935 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 430 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which N/A observational registry is the first listed.
NCT05095935 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05095935 about?
NCT05095935 is a clinical study titled "Medtronic Signia SDR Product Surveillance Registry". The purpose of the registry is to confirm the safety and performance of the Signia™ Small Diameter Reload (SDR) when used in surgical procedures in a real-world setting in patients receiving surgery for indicated thoracic, abdominal, and pediatric applications, intraoperatively.
What is the current status of trial NCT05095935?
This trial is currently completed. The enrollment target is 430 participants. The study started on 2021-08-10. Estimated completion is 2024-10-01.
What interventions are being tested in trial NCT05095935?
The interventions under investigation include: N/A observational registry (OTHER).
Who is sponsoring clinical trial NCT05095935?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.